[1] CRUZ-JENTOFT AJ, SAYER AA. Sarcopenia. Lancet. 2019;393(10191): 2636-2646.
[2] 孔洁,李树铁,黄攀登,等.中国老年居民肌肉减少症与全因死亡率的关联实证分析[J/OL].上海预防医学,1-14[2025-01-21].http://kns.cnki.net/kcms/detail/31.1635.R.20250107.1507.006.html.
[3] GILLESPIE LD, ROBERTSON MC, GILLESPIE WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;2012(9):CD007146.
[4] CRUZ-JENTOFT AJ, BAHAT G, BAUER J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48(4):601.
[5] COLETTI C, ACOSTA GF, KESLACY S, et al. Exercise-mediated reinnervation of skeletal muscle in elderly people: An update. Eur J Transl Myol. 2022;32(1):10416.
[6] NORDSBORG NB, BONNE TC, BREENFELDT ANDERSEN A, et al. Glucocorticoids Accelerate Erythropoiesis in Healthy Humans-Should the Use in Sports Be Reevaluated? Med Sci Sports Exerc. 2023;55(7): 1334-1341.
[7] ZHANG L, LI M, WANG W, et al. Celecoxib alleviates denervation-induced muscle atrophy by suppressing inflammation and oxidative stress and improving microcirculation. Biochem Pharmacol. 2022; 203:115186.
[8] 谢晓婷,何永,马彦韬,等.富血小板血浆结合周期性机械牵拉对C2C12肌管萎缩的影响及机制探讨[J].中国康复医学杂志,2025, 40(1):8-14.
[9] 白雪,崔立敏,许佳阳.肌少症筛查、评估工具及干预措施的研究进展[J].吉林医药学院学报,2025,46(4):295-300.
[10] 杜倩,李小会,陈丽名,等.中药基于“肠-肌肉轴”及肠道菌群治疗慢性肾脏病肌少症研究进展[J/OL].中医学报,1-8[2024-10-21].http://kns.cnki.net/kcms/detail/41.1411.R.20240808.1328.030.html.
[11] 侯成志,韩佳童,魏光成,等.骨疏康干预破骨细胞:激活核因子E2相关因子2调控c-Fos/NFATc1通路[J].中国组织工程研究, 2025,29(2):279-285.
[12] 唐彬彬,袁一峰,刘康,等.骨疏康颗粒影响破骨细胞外泌体治疗绝经后骨质疏松的机制研究[J].中国中西医结合杂志,2024,44(3): 339-347.
[13] 徐叔云,卞如濂,陈修主编.药理实验方法学[M].3版.北京:人民卫生出版社,2002:911-916.
[14] 张瑞鹏,李杰.lncRNA GPRC5D-AS1对地塞米松诱导小鼠成肌细胞肌萎缩的抵抗和再生作用及其机制[J].吉林大学学报(医学版), 2023,49(6):1457-1465.
[15] 刘桂敏,孙建辉,李建良,等.肾虚证临床与动物实验研究进展[J].中国实验方剂学杂志,2024,30(23):269-280.
[16] GIACOMELLO M, PYAKUREL A, GLYTSOU C, et al. The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol. 2020;21(4): 204-224.
[17] RAPAPORT D, NEUPERT W, LILL R. Mitochondrial protein import. Tom40 plays a major role in targeting and translocation of preproteins by forming a specific binding site for the presequence. J Biol Chem. 1997;272(30):18725-18731.
[18] LÓPEZ-OTÍN C, BLASCO MA, PARTRIDGE L, et al. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278.
[19] WANG S, HE F, WU H, et al. Health-Promoting Activities and Associated Mechanisms of Polygonati Rhizoma Polysaccharides. Molecules. 2023;28(3):1350.
[20] SHAO S, YE X, SU W, et al. Curcumin alleviates Alzheimer’s disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway. J Chem Neuroanat. 2023;134:102363.
[21] TIAN X, LIANG T, LIU Y, et al. Extraction, Structural Characterization, and Biological Functions of Lycium Barbarum Polysaccharides: A Review. Biomolecules. 2019;9(9):389.
[22] LIU H, ZHEN C, XIE J, et al. TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic mitochondrial DNA. Nat Cell Biol. 2024;26(6):878-891.
[23] ZHANG H, QI G, WANG K, et al. Oxidative stress: Roles in skeletal muscle atrophy. Biochem Pharmacol. 2023;214:115664.
[24] BJØRKØY G, LAMARK T, BRECH A, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 2005;171(4):603-614.
[25] MIZUSHIMA N, KOMATSU M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728-741.
[26] HAJAM YA, RANI R, GANIE SY, et al. Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives. Cells. 2022;11(3):552.
[27] CHEN C, ZHOU M, GE Y, et al. SIRT1 and aging related signaling pathways. Mech Ageing Dev. 2020;187:111215.
[28] OWJFARD M, RAHIMIAN Z, KARIMI F, et al. A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke. Heliyon. 2024;10(14):e34121.
[29] 谭敏,黄丽端,侯艳红,等.补骨脂异黄酮调控SIRT1/NF-κB依赖的信号通路抑制Ang II诱导的心肌肥大[J].中国药理学通报,2025, 41(6):1142-1148.
[30] MUNTEANU C, ONOSE G, POȘTARU M, et al. Hydrogen Sulfide and Gut Microbiota: Their Synergistic Role in Modulating Sirtuin Activity and Potential Therapeutic Implications for Neurodegenerative Diseases. Pharmaceuticals (Basel). 2024;17(11):1480.
[31] SIRELKHATIM A, MAHMUD S, SEENI A, et al. Review on Zinc Oxide Nanoparticles: Antibacterial Activity and Toxicity Mechanism. Nanomicro Lett. 2015;7(3):219-242.
[32] 郭孝静,秦欢,项栋良,等.铁死亡在骨关节炎中的作用及中医药干预研究进展[J].中国实验方剂学杂志,2024,30(19):263-272.
[33] OKOYE CN, KOREN SA, WOJTOVICH AP. Mitochondrial complex I ROS production and redox signaling in hypoxia. Redox Biol. 2023;67: 102926.
[34] 高松林,韦柳婷,管晓,等.基于生物信息学分析非酒精性脂肪性肝病的线粒体自噬相关基因及防治中药筛选[J].中草药,2024, 55(19):6655-6665.
[35] ZHAO L, ZHANG H, LI N, et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol. 2023;309:116306.
[36] WEI Z, CHEN J, ZUO F, et al. Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review. J Ethnopharmacol. 2023;300:115748.
[37] LOCKETT J, INDER WJ, CLIFTON VL. The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity. Endocr Rev. 2024;45(4):593-624.
[38] ZHANG X, FENG C, YUAN T, et al. Inhibition of protein disulfide isomerase mitigates steroid-induced osteonecrosis of the femoral head by suppressing osteoclast activity through the reduction of cellular oxidative stress. Chem Biol Interact. 2024;404:111263.
[39] HUANG M, YAN Y, DENG Z, et al. Saikosaponin A and D attenuate skeletal muscle atrophy in chronic kidney disease by reducing oxidative stress through activation of PI3K/AKT/Nrf2 pathway. Phytomedicine. 2023;114:154766.
[40] 商岚清,刘永智,周广智,等.从“骨肉不相亲”探讨牛膝活性成分β-蜕皮甾酮论治骨质疏松的研究进展[J].中华中医药学刊, 2024,42(4):254-258.
[41] 朱汉民,王松,肖文琳,等.线粒体自噬调控骨代谢[J].中国组织工程研究,2025,29(8):1676-1683.
[42] 钱琨,李子卿,孙水.内质网应激与常见退行性骨骼疾病的发生与发展[J].中国组织工程研究,2025,29(6):1285-1295.
|